CF
SNY icon

Cantor Fitzgerald’s Sanofi SNY Stock Holding History

Cantor Fitzgerald’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-45,000
Closed -$2.5M – 528
2025
Q1 		$2.5M Buy
+45,000
New +$2.44M 0.05% 73
2023
Q4 		– Sell
-80,455
Closed -$4.32M – 515
2023
Q3 		$4.32M Buy
+80,455
New +$4.29M 0.12% 181
2023
Q2 		– Sell
-110,887
Closed -$6.03M – 644
2023
Q1 		$6.03M Buy
+110,887
New +$5.39M 0.13% 220
2022
Q1 		– Sell
-10,264
Closed -$514K – 433
2021
Q4 		$514K Buy
+10,264
New +$508K 0.04% 235

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Cantor Fitzgerald's SNY Position: Q2 2025 in Review

Cantor Fitzgerald sold out of Sanofi (SNY) in Q2 2025, closing a stake of 45,000 shares — an estimated $2.5M sold.

Cantor Fitzgerald first reported a position in SNY in Q4 2021 and held it in 4 quarters. The position peaked at $6.03M in Q1 2023. 731 funds tracked by Wall St. Rank hold SNY as of Q2 2025.

  • Cantor Fitzgerald reported no remaining Sanofi position as of Q2 2025 after selling out during the quarter.
  • Cantor Fitzgerald sold 45,000 Sanofi shares in Q2 2025, an estimated $2.5M.
  • Cantor Fitzgerald first reported a position in Sanofi in Q4 2021 and held it in 4 quarters.
  • Cantor Fitzgerald's Sanofi position peaked at $6.03M in Q1 2023.
  • 731 funds tracked by Wall St. Rank held Sanofi as of Q2 2025.

Based on Cantor Fitzgerald's 13F filing for Q2 2025, filed 14 Aug 2025.